Global Imipenem API Sales Market Report 2024

Report ID: 883991 | Published Date: Sep 2024 | No. of Page: 145 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
1 Imipenem API Market Overview
    1.1 Imipenem API Product Scope
    1.2 Imipenem API Segment by Type
        1.2.1 Global Imipenem API Sales by Type (2016 & 2021 & 2027)
        1.2.2 Aseptic API
        1.2.3 Non-sterile API
    1.3 Imipenem API Segment by Application
        1.3.1 Global Imipenem API Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Intramuscular Injection
        1.3.3 Static Drops
    1.4 Imipenem API Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Imipenem API Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Imipenem API Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Imipenem API Price Trends (2016-2027)

2 Imipenem API Estimates and Forecasts by Region
    2.1 Global Imipenem API Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Imipenem API Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Imipenem API Sales Market Share by Region (2016-2021)
        2.2.2 Global Imipenem API Revenue Market Share by Region (2016-2021)
    2.3 Global Imipenem API Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Imipenem API Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Imipenem API Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Imipenem API Estimates and Projections (2016-2027)
        2.4.2 Europe Imipenem API Estimates and Projections (2016-2027)
        2.4.3 China Imipenem API Estimates and Projections (2016-2027)
        2.4.4 Japan Imipenem API Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Imipenem API Estimates and Projections (2016-2027)
        2.4.6 India Imipenem API Estimates and Projections (2016-2027)
3 Global Imipenem API Competition Landscape by Players
    3.1 Global Top Imipenem API Players by Sales (2016-2021)
    3.2 Global Top Imipenem API Players by Revenue (2016-2021)
    3.3 Global Imipenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imipenem API as of 2020)
    3.4 Global Imipenem API Average Price by Company (2016-2021)
    3.5 Manufacturers Imipenem API Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Imipenem API Market Size by Type
    4.1 Global Imipenem API Historic Market Review by Type (2016-2021)
        4.1.1 Global Imipenem API Sales Market Share by Type (2016-2021)
        4.1.2 Global Imipenem API Revenue Market Share by Type (2016-2021)
        4.1.3 Global Imipenem API Price by Type (2016-2021)
    4.2 Global Imipenem API Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Imipenem API Sales Forecast by Type (2022-2027)
        4.2.2 Global Imipenem API Revenue Forecast by Type (2022-2027)
        4.2.3 Global Imipenem API Price Forecast by Type (2022-2027)
5 Global Imipenem API Market Size by Application
    5.1 Global Imipenem API Historic Market Review by Application (2016-2021)
        5.1.1 Global Imipenem API Sales Market Share by Application (2016-2021)
        5.1.2 Global Imipenem API Revenue Market Share by Application (2016-2021)
        5.1.3 Global Imipenem API Price by Application (2016-2021)
    5.2 Global Imipenem API Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Imipenem API Sales Forecast by Application (2022-2027)
        5.2.2 Global Imipenem API Revenue Forecast by Application (2022-2027)
        5.2.3 Global Imipenem API Price Forecast by Application (2022-2027)

6 North America Imipenem API Market Facts & Figures
    6.1 North America Imipenem API Sales by Company
        6.1.1 North America Imipenem API Sales by Company (2016-2021)
        6.1.2 North America Imipenem API Revenue by Company (2016-2021)
    6.2 North America Imipenem API Sales Breakdown by Type
        6.2.1 North America Imipenem API Sales Breakdown by Type (2016-2021)
        6.2.2 North America Imipenem API Sales Breakdown by Type (2022-2027)
    6.3 North America Imipenem API Sales Breakdown by Application
        6.3.1 North America Imipenem API Sales Breakdown by Application (2016-2021)
        6.3.2 North America Imipenem API Sales Breakdown by Application (2022-2027)

7 Europe Imipenem API Market Facts & Figures
    7.1 Europe Imipenem API Sales by Company
        7.1.1 Europe Imipenem API Sales by Company (2016-2021)
        7.1.2 Europe Imipenem API Revenue by Company (2016-2021)
    7.2 Europe Imipenem API Sales Breakdown by Type
        7.2.1 Europe Imipenem API Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Imipenem API Sales Breakdown by Type (2022-2027)
    7.3 Europe Imipenem API Sales Breakdown by Application
        7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Imipenem API Market Facts & Figures
    8.1 China Imipenem API Sales by Company
        8.1.1 China Imipenem API Sales by Company (2016-2021)
        8.1.2 China Imipenem API Revenue by Company (2016-2021)
    8.2 China Imipenem API Sales Breakdown by Type
        8.2.1 China Imipenem API Sales Breakdown by Type (2016-2021)
        8.2.2 China Imipenem API Sales Breakdown by Type (2022-2027)
    8.3 China Imipenem API Sales Breakdown by Application
        8.3.1 China 315 Sales Breakdown by Application (2016-2021)
        8.3.2 China 315 Sales Breakdown by Application (2022-2027)

9 Japan Imipenem API Market Facts & Figures
    9.1 Japan Imipenem API Sales by Company
        9.1.1 Japan Imipenem API Sales by Company (2016-2021)
        9.1.2 Japan Imipenem API Revenue by Company (2016-2021)
    9.2 Japan Imipenem API Sales Breakdown by Type
        9.2.1 Japan Imipenem API Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Imipenem API Sales Breakdown by Type (2022-2027)
    9.3 Japan Imipenem API Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Imipenem API Market Facts & Figures
    10.1 Southeast Asia Imipenem API Sales by Company
        10.1.1 Southeast Asia Imipenem API Sales by Company (2016-2021)
        10.1.2 Southeast Asia Imipenem API Revenue by Company (2016-2021)
    10.2 Southeast Asia Imipenem API Sales Breakdown by Type
        10.2.1 Southeast Asia Imipenem API Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Imipenem API Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Imipenem API Sales Breakdown by Application
        10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Imipenem API Market Facts & Figures
    11.1 India Imipenem API Sales by Company
        11.1.1 India Imipenem API Sales by Company (2016-2021)
        11.1.2 India Imipenem API Revenue by Company (2016-2021)
    11.2 India Imipenem API Sales Breakdown by Type
        11.2.1 India Imipenem API Sales Breakdown by Type (2016-2021)
        11.2.2 India Imipenem API Sales Breakdown by Type (2022-2027)
    11.3 India Imipenem API Sales Breakdown by Application
        11.3.1 India Imipenem API Sales Breakdown by Application (2016-2021)
        11.3.2 India Imipenem API Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Imipenem API Business
    12.1 Hospira
        12.1.1 Hospira Corporation Information
        12.1.2 Hospira Business Overview
        12.1.3 Hospira Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Hospira Imipenem API Products Offered
        12.1.5 Hospira Recent Development
    12.2 ACS DOBFAR SPA
        12.2.1 ACS DOBFAR SPA Corporation Information
        12.2.2 ACS DOBFAR SPA Business Overview
        12.2.3 ACS DOBFAR SPA Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 ACS DOBFAR SPA Imipenem API Products Offered
        12.2.5 ACS DOBFAR SPA Recent Development
    12.3 High Science
        12.3.1 High Science Corporation Information
        12.3.2 High Science Business Overview
        12.3.3 High Science Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 High Science Imipenem API Products Offered
        12.3.5 High Science Recent Development
    12.4 Jeil Pharmaceutica
        12.4.1 Jeil Pharmaceutica Corporation Information
        12.4.2 Jeil Pharmaceutica Business Overview
        12.4.3 Jeil Pharmaceutica Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Jeil Pharmaceutica Imipenem API Products Offered
        12.4.5 Jeil Pharmaceutica Recent Development
    12.5 Choongwae Pharma Corporation
        12.5.1 Choongwae Pharma Corporation Corporation Information
        12.5.2 Choongwae Pharma Corporation Business Overview
        12.5.3 Choongwae Pharma Corporation Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Choongwae Pharma Corporation Imipenem API Products Offered
        12.5.5 Choongwae Pharma Corporation Recent Development
    12.6 Sun Pharmaceutical
        12.6.1 Sun Pharmaceutical Corporation Information
        12.6.2 Sun Pharmaceutical Business Overview
        12.6.3 Sun Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Sun Pharmaceutical Imipenem API Products Offered
        12.6.5 Sun Pharmaceutical Recent Development
    12.7 Sandoz
        12.7.1 Sandoz Corporation Information
        12.7.2 Sandoz Business Overview
        12.7.3 Sandoz Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Sandoz Imipenem API Products Offered
        12.7.5 Sandoz Recent Development
    12.8 Kaliberr
        12.8.1 Kaliberr Corporation Information
        12.8.2 Kaliberr Business Overview
        12.8.3 Kaliberr Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Kaliberr Imipenem API Products Offered
        12.8.5 Kaliberr Recent Development
    12.9 Auronext Pharma
        12.9.1 Auronext Pharma Corporation Information
        12.9.2 Auronext Pharma Business Overview
        12.9.3 Auronext Pharma Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Auronext Pharma Imipenem API Products Offered
        12.9.5 Auronext Pharma Recent Development
    12.10 Nectar Lifesciences
        12.10.1 Nectar Lifesciences Corporation Information
        12.10.2 Nectar Lifesciences Business Overview
        12.10.3 Nectar Lifesciences Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Nectar Lifesciences Imipenem API Products Offered
        12.10.5 Nectar Lifesciences Recent Development
    12.11 Savior Lifetec Corporation
        12.11.1 Savior Lifetec Corporation Corporation Information
        12.11.2 Savior Lifetec Corporation Business Overview
        12.11.3 Savior Lifetec Corporation Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Savior Lifetec Corporation Imipenem API Products Offered
        12.11.5 Savior Lifetec Corporation Recent Development
    12.12 Zhuhai United Laboratorie
        12.12.1 Zhuhai United Laboratorie Corporation Information
        12.12.2 Zhuhai United Laboratorie Business Overview
        12.12.3 Zhuhai United Laboratorie Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Zhuhai United Laboratorie Imipenem API Products Offered
        12.12.5 Zhuhai United Laboratorie Recent Development
    12.13 SUZHOU HOMESUN PHARMACEUTICAL
        12.13.1 SUZHOU HOMESUN PHARMACEUTICAL Corporation Information
        12.13.2 SUZHOU HOMESUN PHARMACEUTICAL Business Overview
        12.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Products Offered
        12.13.5 SUZHOU HOMESUN PHARMACEUTICAL Recent Development
    12.14 Unimark Remedies
        12.14.1 Unimark Remedies Corporation Information
        12.14.2 Unimark Remedies Business Overview
        12.14.3 Unimark Remedies Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Unimark Remedies Imipenem API Products Offered
        12.14.5 Unimark Remedies Recent Development
    12.15 Zhejiang Haixiang Pharmaceutical
        12.15.1 Zhejiang Haixiang Pharmaceutical Corporation Information
        12.15.2 Zhejiang Haixiang Pharmaceutical Business Overview
        12.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Zhejiang Haixiang Pharmaceutical Imipenem API Products Offered
        12.15.5 Zhejiang Haixiang Pharmaceutical Recent Development

13 Imipenem API Manufacturing Cost Analysis
    13.1 Imipenem API Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Imipenem API
    13.4 Imipenem API Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Imipenem API Distributors List
    14.3 Imipenem API Customers

15 Market Dynamics
    15.1 Imipenem API Market Trends
    15.2 Imipenem API Drivers
    15.3 Imipenem API Market Challenges
    15.4 Imipenem API Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Imipenem API Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Imipenem API Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Imipenem API Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Imipenem API Sales (KG) by Region (2016-2021)
    Table 5. Global Imipenem API Sales Market Share by Region (2016-2021)
    Table 6. Global Imipenem API Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Imipenem API Revenue Share by Region (2016-2021)
    Table 8. Global Imipenem API Sales (KG) Forecast by Region (2022-2027)
    Table 9. Global Imipenem API Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Imipenem API Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Imipenem API Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Imipenem API Sales (KG) of Key Companies (2016-2021)
    Table 13. Global Imipenem API Sales Share by Company (2016-2021)
    Table 14. Global Imipenem API Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Imipenem API Revenue Share by Company (2016-2021)
    Table 16. Global Imipenem API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imipenem API as of 2020)
    Table 17. Global Imipenem API Average Price (US$/G) of Key Company (2016-2021)
    Table 18. Manufacturers Imipenem API Manufacturing Sites and Area Served
    Table 19. Manufacturers Imipenem API Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Imipenem API Sales (KG) by Type (2016-2021)
    Table 22. Global Imipenem API Sales Share by Type (2016-2021)
    Table 23. Global Imipenem API Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Imipenem API Price (US$/G) by Type (2016-2021)
    Table 25. Global Imipenem API Sales Share by Type (2022-2027)
    Table 26. Global Imipenem API Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Imipenem API Revenue Share by Type (2022-2027)
    Table 28. Global Imipenem API Price (US$/G) by Type (2022-2027)
    Table 29. Global Imipenem API Sales (KG) by Application (2016-2021) 
    Table 30. Global Imipenem API Sales Share by Application (2016-2021)
    Table 31. Global Imipenem API Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Imipenem API Price (US$/G) by Application (2016-2021)
    Table 33. Global Imipenem API Sales (KG) by Application (2022-2027)
    Table 34. Global Imipenem API Sales Share by Application (2022-2027)
    Table 35. Global Imipenem API Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Imipenem API Revenue Share by Application (2022-2027)
    Table 37. Global Imipenem API Price (US$/G) by Application (2022-2027)
    Table 38. North America Imipenem API Sales (KG) by Company (2016-2021)
    Table 39. North America Imipenem API Sales Market Share by Company (2016-2021)
    Table 40. North America Imipenem API Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Imipenem API Revenue Market Share by Company (2016-2021)
    Table 42. North America Imipenem API Sales by Type (2016-2021) & (KG)
    Table 43. North America Imipenem API Sales Market Share by Type (2016-2021)
    Table 44. North America Imipenem API Sales by Type (2022-2027) & (KG)
    Table 45. North America Imipenem API Sales Market Share by Type (2022-2027)
    Table 46. North America Imipenem API Sales by Application (2016-2021) & (KG)
    Table 47. North America Imipenem API Sales Market Share by Application (2016-2021)
    Table 48. North America Imipenem API Sales by Application (2022-2027) & (KG)
    Table 49. North America Imipenem API Sales Market Share by Application (2022-2027)
    Table 50. Europe Imipenem API Sales (KG) by Company (2016-2021)
    Table 51. Europe Imipenem API Sales Market Share by Company (2016-2021)
    Table 52. Europe Imipenem API Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Imipenem API Revenue Market Share by Company (2016-2021)
    Table 54. Europe Imipenem API Sales by Type (2016-2021) & (KG)
    Table 55. Europe Imipenem API Sales Market Share by Type (2016-2021)
    Table 56. Europe Imipenem API Sales by Type (2022-2027) & (KG)
    Table 57. Europe Imipenem API Sales Market Share by Type (2022-2027)
    Table 58. Europe Imipenem API Sales by Application (2016-2021) & (KG)
    Table 59. Europe Imipenem API Sales Market Share by Application (2016-2021)
    Table 60. Europe Imipenem API Sales by Application (2022-2027) & (KG)
    Table 61. Europe Imipenem API Sales Market Share by Application (2022-2027)
    Table 62. China Imipenem API Sales (KG) by Company (2016-2021)
    Table 63. China Imipenem API Sales Market Share by Company (2016-2021)
    Table 64. China Imipenem API Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Imipenem API Revenue Market Share by Company (2016-2021)
    Table 66. China Imipenem API Sales by Type (2016-2021) & (KG)
    Table 67. China Imipenem API Sales Market Share by Type (2016-2021)
    Table 68. China Imipenem API Sales by Type (2022-2027) & (KG)
    Table 69. China Imipenem API Sales Market Share by Type (2022-2027)
    Table 70. China Imipenem API Sales by Application (2016-2021) & (KG)
    Table 71. China Imipenem API Sales Market Share by Application (2016-2021)
    Table 72. China Imipenem API Sales by Application (2022-2027) & (KG)
    Table 73. China Imipenem API Sales Market Share by Application (2022-2027)
    Table 74. Japan Imipenem API Sales (KG) by Company (2016-2021)
    Table 75. Japan Imipenem API Sales Market Share by Company (2016-2021)
    Table 76. Japan Imipenem API Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Imipenem API Revenue Market Share by Company (2016-2021)
    Table 78. Japan Imipenem API Sales by Type (2016-2021) & (KG)
    Table 79. Japan Imipenem API Sales Market Share by Type (2016-2021)
    Table 80. Japan Imipenem API Sales by Type (2022-2027) & (KG)
    Table 81. Japan Imipenem API Sales Market Share by Type (2022-2027)
    Table 82. Japan Imipenem API Sales by Application (2016-2021) & (KG)
    Table 83. Japan Imipenem API Sales Market Share by Application (2016-2021)
    Table 84. Japan Imipenem API Sales by Application (2022-2027) & (KG)
    Table 85. Japan Imipenem API Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Imipenem API Sales (KG) by Company (2016-2021)
    Table 87. Southeast Asia Imipenem API Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Imipenem API Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Imipenem API Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Imipenem API Sales by Type (2016-2021) & (KG)
    Table 91. Southeast Asia Imipenem API Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Imipenem API Sales by Type (2022-2027) & (KG)
    Table 93. Southeast Asia Imipenem API Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Imipenem API Sales by Application (2016-2021) & (KG)
    Table 95. Southeast Asia Imipenem API Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Imipenem API Sales by Application (2022-2027) & (KG)
    Table 97. Southeast Asia Imipenem API Sales Market Share by Application (2022-2027)
    Table 98. India Imipenem API Sales (KG) by Company (2016-2021)
    Table 99. India Imipenem API Sales Market Share by Company (2016-2021)
    Table 100. India Imipenem API Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Imipenem API Revenue Market Share by Company (2016-2021)
    Table 102. India Imipenem API Sales by Type (2016-2021) & (KG)
    Table 103. India Imipenem API Sales Market Share by Type (2016-2021)
    Table 104. India Imipenem API Sales by Type (2022-2027) & (KG)
    Table 105. India Imipenem API Sales Market Share by Type (2022-2027)
    Table 106. India Imipenem API Sales by Application (2016-2021) & (KG)
    Table 107. India Imipenem API Sales Market Share by Application (2016-2021)
    Table 108. India Imipenem API Sales by Application (2022-2027) & (KG)
    Table 109. India Imipenem API Sales Market Share by Application (2022-2027)
    Table 110. Hospira Corporation Information
    Table 111. Hospira Description and Business Overview
    Table 112. Hospira Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 113. Hospira Imipenem API Product
    Table 114. Hospira Recent Development
    Table 115. ACS DOBFAR SPA Corporation Information
    Table 116. ACS DOBFAR SPA Description and Business Overview
    Table 117. ACS DOBFAR SPA Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 118. ACS DOBFAR SPA Imipenem API Product
    Table 119. ACS DOBFAR SPA Recent Development
    Table 120. High Science Corporation Information
    Table 121. High Science Description and Business Overview
    Table 122. High Science Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 123. High Science Imipenem API Product
    Table 124. High Science Recent Development
    Table 125. Jeil Pharmaceutica Corporation Information
    Table 126. Jeil Pharmaceutica Description and Business Overview
    Table 127. Jeil Pharmaceutica Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 128. Jeil Pharmaceutica Imipenem API Product
    Table 129. Jeil Pharmaceutica Recent Development
    Table 130. Choongwae Pharma Corporation Corporation Information
    Table 131. Choongwae Pharma Corporation Description and Business Overview
    Table 132. Choongwae Pharma Corporation Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 133. Choongwae Pharma Corporation Imipenem API Product
    Table 134. Choongwae Pharma Corporation Recent Development
    Table 135. Sun Pharmaceutical Corporation Information
    Table 136. Sun Pharmaceutical Description and Business Overview
    Table 137. Sun Pharmaceutical Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 138. Sun Pharmaceutical Imipenem API Product
    Table 139. Sun Pharmaceutical Recent Development
    Table 140. Sandoz Corporation Information
    Table 141. Sandoz Description and Business Overview
    Table 142. Sandoz Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 143. Sandoz Imipenem API Product
    Table 144. Sandoz Recent Development
    Table 145. Kaliberr Corporation Information
    Table 146. Kaliberr Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 147. Kaliberr Description and Business Overview
    Table 148. Kaliberr Imipenem API Product
    Table 149. Kaliberr Recent Development
    Table 150. Auronext Pharma Corporation Information
    Table 151. Auronext Pharma Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 152. Auronext Pharma Description and Business Overview
    Table 153. Auronext Pharma Imipenem API Product
    Table 154. Auronext Pharma Recent Development
    Table 155. Nectar Lifesciences Corporation Information
    Table 156. Nectar Lifesciences Description and Business Overview
    Table 157. Nectar Lifesciences Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 158. Nectar Lifesciences Imipenem API Product
    Table 159. Nectar Lifesciences Recent Development
    Table 160. Savior Lifetec Corporation Corporation Information
    Table 161. Savior Lifetec Corporation Description and Business Overview
    Table 162. Savior Lifetec Corporation Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 163. Savior Lifetec Corporation Imipenem API Product
    Table 164. Savior Lifetec Corporation Recent Development
    Table 165. Zhuhai United Laboratorie Corporation Information
    Table 166. Zhuhai United Laboratorie Description and Business Overview
    Table 167. Zhuhai United Laboratorie Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 168. Zhuhai United Laboratorie Imipenem API Product
    Table 169. Zhuhai United Laboratorie Recent Development
    Table 170. SUZHOU HOMESUN PHARMACEUTICAL Corporation Information
    Table 171. SUZHOU HOMESUN PHARMACEUTICAL Description and Business Overview
    Table 172. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 173. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product
    Table 174. SUZHOU HOMESUN PHARMACEUTICAL Recent Development
    Table 175. Unimark Remedies Corporation Information
    Table 176. Unimark Remedies Description and Business Overview
    Table 177. Unimark Remedies Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 178. Unimark Remedies Imipenem API Product
    Table 179. Unimark Remedies Recent Development
    Table 180. Zhejiang Haixiang Pharmaceutical Corporation Information
    Table 181. Zhejiang Haixiang Pharmaceutical Description and Business Overview
    Table 182. Zhejiang Haixiang Pharmaceutical Imipenem API Sales (KG), Revenue (Million USD), Price (US$/G) and Gross Margin (2016-2021)
    Table 183. Zhejiang Haixiang Pharmaceutical Imipenem API Product
    Table 184. Zhejiang Haixiang Pharmaceutical Recent Development
    Table 185. Production Base and Market Concentration Rate of Raw Material
    Table 186. Key Suppliers of Raw Materials
    Table 187. Imipenem API Distributors List
    Table 188. Imipenem API Customers List
    Table 189. Imipenem API Market Trends
    Table 190. Imipenem API Market Drivers
    Table 191. Imipenem API Market Challenges
    Table 192. Imipenem API Market Restraints
    Table 193. Research Programs/Design for This Report
    Table 194. Key Data Information from Secondary Sources
    Table 195. Key Data Information from Primary Sources
List of Figures
    Figure 1. Imipenem API Product Picture
    Figure 2. Global Imipenem API Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Imipenem API Sales Market Share by Application in 2021 & 2027
    Figure 6. Intramuscular Injection Examples
    Figure 7. Static Drops Examples
    Figure 8. Global Imipenem API Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Imipenem API Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global Imipenem API Sales (KG) Growth Rate (2016-2027)
    Figure 11. Global Imipenem API Price Trends Growth Rate (2016-2027) (US$/G)
    Figure 12. Global Imipenem API Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global Imipenem API Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America Imipenem API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America Imipenem API Sales (KG) Growth Rate (2016-2027)
    Figure 16. Europe Imipenem API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe Imipenem API Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China Imipenem API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China Imipenem API Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan Imipenem API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan Imipenem API Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia Imipenem API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Imipenem API Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India Imipenem API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India Imipenem API Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest Imipenem API Players Market Share by Revenue in Imipenem API: 2016 & 2020
    Figure 27. Imipenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Imipenem API Revenue Share by Type (2016-2021)
    Figure 29. Global Imipenem API Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global Imipenem API Revenue Share by Application (2016-2021)
    Figure 31. Global Imipenem API Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America Imipenem API Sales Market Share by Type in 2020
    Figure 33. North America Imipenem API Sales Market Share by Application in 2020
    Figure 34. Europe Imipenem API Sales Market Share by Type in 2020
    Figure 35. Europe Imipenem API Sales Market Share by Application in 2020
    Figure 36. China Imipenem API Sales Market Share by Type in 2020
    Figure 37. China Imipenem API Sales Market Share by Application in 2020
    Figure 38. Japan Imipenem API Sales Market Share by Type in 2020
    Figure 39. Japan Imipenem API Sales Market Share by Application in 2020
    Figure 40. Southeast Asia Imipenem API Sales Market Share by Type in 2020
    Figure 41. Southeast Asia Imipenem API Sales Market Share by Application in 2020
    Figure 42. India Imipenem API Sales Market Share by Type in 2020
    Figure 43. India Imipenem API Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of Imipenem API 
    Figure 46. Manufacturing Process Analysis of Imipenem API
    Figure 47. Imipenem API Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation 
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hospira
ACS DOBFAR SPA
High Science
Jeil Pharmaceutica
Choongwae Pharma Corporation
Sun Pharmaceutical
Sandoz
Kaliberr
Auronext Pharma
Nectar Lifesciences
Savior Lifetec Corporation
Zhuhai United Laboratorie
SUZHOU HOMESUN PHARMACEUTICAL
Unimark Remedies
Zhejiang Haixiang Pharmaceutical
Frequently Asked Questions
Imipenem API report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Imipenem API report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Imipenem API report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Valacyclovir

The global Valacyclovir market is segmented by company, region (country), by Type, and by Applica ... Read More

Cefepime

The global Cefepime market is segmented by company, region (country), by Type, and by Application ... Read More

Omnicef

The global Omnicef market is segmented by company, region (country), by Type, and by Application. ... Read More

Levonorgestrel API

The global Levonorgestrel API market is segmented by company, region (country), by Type, and by A ... Read More